Skip to Content
🌐Ship toSelect country

Juvederm Ultra 3 Lidocaine - 2 x 1,0ml

Juvéderm Ultra 3 is an Allergan hyaluronic acid dermal filler built on Hylacross cross-linking technology, containing 24 mg/ml HA and 0.3% lidocaine. It is indicated for injection into the mid-to-deep dermis to correct moderate to deep facial wrinkles and folds, such as nasolabial folds, and for lip definition and volume enhancement. The gel's cohesive, smooth consistency allows even distribution and a natural, soft feel in areas of facial movement. Clinical and manufacturer information cites results lasting up to around 12 months. For use by licensed, trained medical practitioners only.

162.00 € 162.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand JUVÉDERM®
SKU A0103 Share
Treatment Areas LipsMarionette LinesNasolabial folds
Tags Cross-Linked Hyaluronic AcidLidocaine

Juvederm Ultra 3 is a mid-viscosity hyaluronic acid dermal filler from Allergan's Juvederm Ultra range, built on Hylacross technology, designed for correction of moderate facial wrinkles and folds such as the nasolabial folds. Formulated with lidocaine for a more comfortable injection experience.

CONCENTRATION

  • Hyaluronic acid 24mg/ml (Hylacross technology)
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 2 x 1.0ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 9-12 months, depending on individual metabolism and treatment area.

INDICATIONS

  • Moderate facial wrinkles and folds
  • Nasolabial folds

TREATMENT AREAS

  • Nasolabial folds
  • Face, general

Juvederm Ultra 3 is injected into the mid to deep dermis using linear threading or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin